Anchorage Capital Group

Latest statistics and disclosures from Anchorage Capital Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are S, DNA, and represent 100.00% of Anchorage Capital Group's stock portfolio.
  • Reduced shares in these 2 stocks: AMBP, AMPWF.
  • Sold out of its positions in AMBP, AMPWF.
  • Anchorage Capital Group was a net seller of stock by $-5.0M.
  • Anchorage Capital Group has $89M in assets under management (AUM), dropping by -24.56%.
  • Central Index Key (CIK): 0001300714

Tip: Access up to 7 years of quarterly data

Positions held by Anchorage Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Anchorage Capital Group

Anchorage Capital Group holds 2 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Sentinelone Cl A (S) 83.6 $74M 4.9M 15.00
 View chart
Ginkgo Bioworks Holdings Cl A New (DNA) 16.4 $15M 1.7M 8.31
 View chart

Past Filings by Anchorage Capital Group

SEC 13F filings are viewable for Anchorage Capital Group going back to 2010

View all past filings